Validation of a liquid chromatography-mass spectrometry method to assess the metabolism of dextromethorphan in rat everted gut sacs

被引:19
作者
Arellano, C
Philibert, C
Yakan, ENDà
Vachoux, C
Lacombe, O
Woodley, J
Houin, G
机构
[1] Fac Pharmaceut Sci, ENVT, INRA, UPTE,UMR 181,Lab Cinet Xenobiot, F-31062 Toulouse, France
[2] CHU Rangueil, Lab Toxicol & Pharmacocinet Clin, F-31043 Toulouse, France
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2005年 / 819卷 / 01期
关键词
dextromethorphan; LC-MS; intestine; metabolism; cytochrome P450;
D O I
10.1016/j.jchromb.2005.01.036
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid, sensitive and selective liquid chromatography-mass spectrometry (LC-MS) method was developed for the simultaneous assay of dextromethorphan and its metabolites in tissue culture medium and its intestinal metabolism studied with the rat everted gut sac model. The method was validated in the concentration range of 0.1-2.5 mu M (27.1 ng/mL-0.677 mu g/mL) for dextromethorphan and 0.005-0.5 mu M for dextrorphan and 3-methoxymorphinan (1.28 ng/mL-0.128 mu g/mL) and 3-hydroxymorphinan (1.22 ng/mL-0.122 mu g/mL). The limits of quantification (LOQ) were 0.0025 mu M (12.5 fmoles, 3.4 pg, 5 mu L injected) for dextromethorphan; 0.0025 mu M for dextrorphan, 3-methoxymorphinan (24.9 fmoles, 6.4 pg injected), and 3-hydroxymorphinan (25.1 fmoles, 6.1 pg injected) with 10 mu L injected. The detection of dextrorphan and 3-methoxymorphinan showed that both the P450 isoforms CYP3A and 2D were active in the intestinal mucosa and metabolised dextromethorphan during its passage across the mucosa. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:105 / 113
页数:9
相关论文
共 44 条
[31]   First-pass metabolism of midazolam by the human intestine [J].
Paine, MF ;
Shen, DD ;
Kunze, KL ;
Perkins, JD ;
Marsh, CL ;
McVicar, JP ;
Barr, DM ;
Gillies, BS ;
Thummel, KE .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (01) :14-24
[32]  
PETERSON GL, 1983, METHOD ENZYMOL, V91, P95
[33]  
Schmider J, 1997, BIOPHARM DRUG DISPOS, V18, P227, DOI 10.1002/(SICI)1099-081X(199704)18:3<227::AID-BDD18>3.0.CO
[34]  
2-L
[35]   Roles of the jejunum and ileum in the first-pass effect as absorptive barriers for orally administered tacrolimus [J].
Shimomura, M ;
Masuda, S ;
Saito, H ;
Sakamoto, S ;
Uemoto, S ;
Tanaka, K ;
Inui, K .
JOURNAL OF SURGICAL RESEARCH, 2002, 103 (02) :215-222
[36]   Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism [J].
Thummel, KE ;
OShea, D ;
Paine, MF ;
Shen, DD ;
Kunze, KL ;
Perkins, JD ;
Wilkinson, GR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (05) :491-502
[37]  
Tyndale RF, 1999, DRUG METAB DISPOS, V27, P924
[38]   P-glycoprotein is a factor in the uptake of dextromethorphan, but not of melperone, into the mouse brain: evidence for an overlap in substrate specificity between P-gp and CYP2D6 [J].
Uhr, M ;
Namendorf, C ;
Grauer, MT ;
Rosenhagen, M ;
Ebinger, M .
JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (04) :509-+
[39]   A sensitive LC-MS/MS assay for the determination of dextromethorphan and metabolites in human urine - application for drug interaction studies assessing potential CYP3A and CYP2D6 inhibition [J].
Vengurlekar, SS ;
Heitkamp, J ;
McCush, F ;
Velagaleti, PR ;
Brisson, JH ;
Bramer, SL .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 30 (01) :113-124
[40]  
WHRIGHTON SA, 2000, METABOLIC DRUG INTER, P115